ENSO (ENSO) fluctuates by 69.3% in 24 hours: Trading volume surges over 100 times, triggering speculative volatility
Bitget Pulse2026/04/26 10:53Brief Volatility Overview
Over the past 24 hours, ENSO's price rebounded from a low of $0.8035 to a high of $1.36, currently quoted at $1.1001, with a fluctuation amplitude of 69.3%. The 24-hour trading volume surged to approximately $262 million, over a hundredfold increase from normal levels (z-score peak at 79.2 and 129.5 times), with spot trading volume up by 203% to $41.1 million, and net capital inflow mainly driven by spot buying.
Brief Analysis of Unusual Movement Causes
- Trading volume increased abnormally by over 100 times, driving sharp price fluctuations: rebounded from a low of $0.785 to a high of $1.1013, accompanied by liquidity hunting and stop-loss sweeps (volume z-score peaks at 129.5 and 7.1 times).
- No official announcements or significant whale transfer records, the movement was purely driven by speculative spot buying demand.
Market Views and Outlook
Community sentiment is cautiously optimistic, with the 1-hour EMA stack bullish, ADX trend strength at 31.4. Mainstream traders suggest waiting for a pullback to the $0.819–0.831 support area for long entries, targeting $0.950–0.987, but cautioning against bull-bear traps. If $0.803 support fails, a further pullback may follow. Bullish voting on the Coingecko community has reached 100%. CMC community posts emphasize a parabolic breakout under high volume support, but stress the need to test the $0.889 resistance level.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
AMD (AMD.US) Surpasses $1 Trillion Market Cap and Begins Competing for "Computing Power Definition Rights"! Officially Announces $8.2 Billion Acquisition of Fei-Fei Li's World Labs
AMD has agreed to acquire World Labs for $8.2 billion, thereby gaining access to the artificial intelligence startup founded by industry pioneer and researcher Fei-Fei Li. This acquisition is expected to help AMD plan its future hardware launches by bringing in a team of top researchers and their models, as well as deep insights into trends in the field of artificial intelligence.
A Major Reversal Amid the U.S. Bond Selloff! Bond Market Veteran Bianco Turns Bullish for the First Time in Six Years, Calling 5% Yield a "Value Buy Opportunity"
Currently, as benchmark U.S. Treasury yields surge to their highest levels in nearly two decades, bond market veteran Jim Bianco has loosened his bearish stance for the first time and is gradually building long positions as a "value buyer."
Crypto prices
More
